Establishment Labs Holdings (ESTA) Free Cash Flow (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly Free Cash Flow of -$6.2 million in Q1 2026, up 0.77% quarter-over-quarter from -$6.2 million in Q4 2025, and up 71.31% on a YoY basis from -$3.6 million in Q1 2025.
Establishment Labs Holdings (ESTA) Free Cash Flow (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Free Cash Flow history runs 10 years deep, the most recent figure standing at -$6.2 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 71.31% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at -$41.6 million (up 43.48% YoY), while the FY2025 annual figure was -$56.9 million, up 11.9% from the prior year.
- Free Cash Flow was -$6.2 million for Q1 2026 at Establishment Labs Holdings, up from -$6.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$5.0 million in Q3 2022 to a low of -$40.3 million in Q3 2023.
- Historically, Free Cash Flow has averaged -$16.8 million across 5 years, with a median of -$15.0 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow slumped 3998.21% in 2022, then surged 75.81% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$15.1 million in 2022, then advanced by 26.19% to -$11.2 million in 2023, then sank by 130.18% to -$25.7 million in 2024, then soared by 75.81% to -$6.2 million in 2025, then grew by 0.77% to -$6.2 million in 2026.
- The last three Free Cash Flow figures came in at -$6.2 million (Q1 2026), -$6.2 million (Q4 2025), and -$8.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn | -6.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.16 Mn |
| Mar 31, 2026 | -6.16 Mn |
| Dec 31, 2025 | -6.21 Mn |
| Dec 31, 2025 | -6.21 Mn |
| Sep 30, 2025 | -8.87 Mn |
| Sep 30, 2025 | -8.87 Mn |
| Jun 30, 2025 | -20.38 Mn |
| Jun 30, 2025 | -20.38 Mn |
| Mar 31, 2025 | -21.48 Mn |
| Mar 31, 2025 | -21.48 Mn |
| Dec 31, 2024 | -25.68 Mn |
| Dec 31, 2024 | -25.68 Mn |
| Sep 30, 2024 | -11.48 Mn |
| Sep 30, 2024 | -11.48 Mn |
| Jun 30, 2024 | -15.01 Mn |
| Jun 30, 2024 | -15.01 Mn |
| Mar 31, 2024 | -12.46 Mn |
| Mar 31, 2024 | -12.46 Mn |
| Dec 31, 2023 | -11.16 Mn |
| Dec 31, 2023 | -11.16 Mn |